Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

620 ARTÍCULOS , VIENDO DEL 406 AL 420

Hypertension and Alzheimer's disease: is the picture any clearer?

Lennon MJ, Koncz R, Sachdev PS.

Curr Opin Psychiatry. 2021 Mar 1;34(2):142-148. doi: 10.1097/YCO.0000000000000684.

Change in cognitive function according to cholinesterase inhibitor use and amyloid PET positivity in patients with mild cognitive impairment

Pyun JM, Ryoo N, Park YH, Kim S.

Alzheimers Res Ther. 2021 Jan 5;13(1):10. doi: 10.1186/s13195-020-00749-5.

Hypertriglyceridemia and Alzheimer Disease: Opening the Mind to New Therapeutic Opportunities

Watts GF, Mamo JCL.

Clin Chem. 2021 Jan 8;67(1):6-8. doi: 10.1093/clinchem/hvaa294.

Crocus Sativus L. (Saffron) in Alzheimer's Disease Treatment: Bioactive Effects on Cognitive Impairment

D'Onofrio G, Nabavi SM, Sancarlo D, Greco A, Pieretti S.

Curr Neuropharmacol. 2021;19(9):1606-1616. doi: 10.2174/1570159X19666210113144703.

New approaches to symptomatic treatments for Alzheimer's disease

Cummings J.

Mol Neurodegener. 2021 Jan 13;16(1):2. doi: 10.1186/s13024-021-00424-9.

Intranasal Insulin for Alzheimer's Disease

Hallschmid M.

CNS Drugs. 2021 Jan;35(1):21-37. doi: 10.1007/s40263-020-00781-x. Epub 2021 Jan 30.

Potential of Caffeine in Alzheimer's Disease-A Review of Experimental Studies

Londzin P, Zamora M, Kąkol B, Taborek A, Folwarczna J.

Nutrients. 2021 Feb 6;13(2):537. doi: 10.3390/nu13020537.

Cannabinoids for Agitation in Alzheimer's Disease

Outen JD, Burhanullah MH, Vandrey R, Amjad H, Harper DG, Patrick RE, May RL, Agronin ME, Forester BP, Rosenberg PB.

Am J Geriatr Psychiatry. 2021 Dec;29(12):1253-1263. doi: 10.1016/j.jagp.2021.01.015. Epub 2021 Jan 27.

Donepezil Combined with DL-3-n-Butylphthalide Delays Cognitive Decline in Patients with Mild to Moderate Alzheimer's Disease: A Multicenter, Prospective Cohort Study

Wang J, Guo X, Lu W, Liu J, Zhang H, Quan Q, Su H, Ma L, Gao F, Qu Q.

J Alzheimers Dis. 2021;80(2):673-681. doi: 10.3233/JAD-201381.

Blinded Clinical Evaluation for Dementia of Alzheimer's Type Classification Using FDG-PET: A Comparison Between Feature-Engineered and Non-Feature-Engineered Machine Learning Methods

Ma D, Yee E, Stocks JK, Jenkins LM, Popuri K, Chausse G, Wang L, Probst S, Beg MF.

J Alzheimers Dis. 2021;80(2):715-726. doi: 10.3233/JAD-201591.

Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials

Lu M, Pontecorvo MJ, Devous MD Sr, Arora AK, Galante N, McGeehan A, Devadanam C, Salloway SP, Doraiswamy PM, Curtis C, Truocchio SP, Flitter M, Locascio T, Devine M, Zimmer JA, Fleisher AS, Mintun MA; AVID Collaborators.

JAMA Neurol. 2021 Apr 1;78(4):445-453. doi: 10.1001/jamaneurol.2020.5505.

AVP-786 as a promising treatment option for Alzheimer's Disease including agitation

Khoury R, Marx C, Mirgati S, Velury D, Chakkamparambil B, Grossberg GT.

Expert Opin Pharmacother. 2021 May;22(7):783-795. doi: 10.1080/14656566.2021.1882995. Epub 2021 Feb 26.

Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis

Ackley SF, Zimmerman SC, Brenowitz WD, Tchetgen Tchetgen EJ, Gold AL, Manly JJ, Mayeda ER, Filshtein TJ, Power MC, Elahi FM, Brickman AM, Glymour MM.

BMJ. 2021 Feb 25;372:n156. doi: 10.1136/bmj.n156.

Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer's Disease

Cheng YJ, Lin CH, Lane HY.

Int J Mol Sci. 2021 Feb 25;22(5):2283. doi: 10.3390/ijms22052283.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias